1,056 hedge funds and large institutions have $36.2B invested in Biogen in 2020 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 337 increasing their positions, 437 reducing their positions, and 130 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

26% less first-time investments, than exits

New positions opened: 96 | Existing positions closed: 130

37% less call options, than puts

Call options by funds: $894M | Put options by funds: $1.43B

57% less funds holding in top 10

Funds holding in top 10: 4921 (-28)

Holders
1,056
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$894M
Puts
$1.43B
Net Calls
Net Calls Change

Top Buyers

1 +$182M
2 +$148M
3 +$142M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$114M
5
AL
AJO LP
Pennsylvania
+$91.1M
Name Holding Trade Value Shares
Change
Change in
Stake
626
$579K
627
$579K
628
$575K
629
$575K
630
$572K
631
$568K
632
$568K
633
$564K
634
$562K
635
$558K
636
$556K
637
$551K
638
$549K
639
$540K
640
$537K
641
$535K
642
$532K
643
$528K
644
$524K
645
$522K
646
$518K
647
$516K
648
$516K
649
$515K
650
$513K